Author:
Zaitsu Kei,Katagi Munehiro,Tatsuno Michiaki,Sato Takako,Tsuchihashi Hitoshi,Suzuki Koichi
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry, medical,Toxicology,Pathology and Forensic Medicine
Reference43 articles.
1. Shulgin AT (1978) Psychotomimetic drugs: structure–activity relationships. In: Iversen LL, Iversen SD, Snyder SH (eds) The handbook of psychopharmacology: stimulants, vol 11. Plenum, New York, pp 243–333
2. Buchanan JF, Brown CR (1988) ‘Designer Drugs’ a problem in clinical toxicology. Med Toxicol Adverse Drug Exp 3:1–17
3. Glennon RA (1989) Stimulus properties of hallucinogenic phenylalkylamines and related designer drugs: formulation of structure–activity relationships. In: Asghar K, Souza ED (eds) Pharmacology and toxicology of amphetamine and related designer drugs. NIDA Research Monograph 94, Superintendent of Documents, U.S. Government Printing Office, Washington D.C., pp 43–67
4. Dal Cason TA, Young R, Glennon RA (1997) Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogues. Pharmacol Biochem Behav 58:1109–1116
5. Parker MA, Marona-Lewicka D, Lucaites VL, Nelson DL, Nichols DE (1998) A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor. J Med Chem 41:5148–5149
Cited by
56 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献